Summary
Long-term studies of α2-PAG in sera of patients with breast cancer, bronchial carcinoma, gynaecological carcinoma, melanoma and laryngeal carcinoma have proved that α2-PAG is a possible laboratory parameter for the assessment of recurrence of tumour and metastasis. The results published for trophoblastic tumour and gastrointestinal carcinoma are still divergent. Because of the large individual range of α2-PAG concentrations and the widely differing α2-PAG levels in men and women single determinations of this protein are without value. A detailed classification of the pathological mechanisms to which these proteins are submitted is still missing and consequently we have no fundamental knowledge of diseases that apart from pregnancy and neoplasia lead to changes in the physiological α2-PAG serum concentration.
Zusammenfassung
Im Rahmen von Longitudinalstudien haben sich α2-PAG-Bestimmungen im Serum von Patienten mit Mammakarzinom, Bronchialkarzinom, gynäkologischem Karzinom, Kehlkopfkarzinom oder Melanom als ein möglicher laborchemischer Parameter erwiesen, um Aussagen über die eingeschlagene Therapie, Tumorrezidive und Metastasen zu machen. Bei trophoblastischen Tumoren und Gastrointestinalkarzinomen sind die bisher publizierten Ergebnisse noch divergierend. Wegen der großen individuellen Strubreite der α2-PAG-Konzentrationen und wegen der stark unterschiedlichen α2-PAG-Spiegel bei Männern und Frauen sind Einzelbestimmungen dieses Proteins ohne Wert. Es fehlt noch eine detaillierte Abklärung über die Pathomechanismen, denen dieses Protein unterliegt, und damit die grundlegende Kenntnis über die Veränderungen, bei denen es neben Schwangerschaft und Neoplasien zu Änderungen des physiologischen α2-PAG-Serummusters kommt.
Similar content being viewed by others
References
Alfonso JF, Farnham NG (1962) Studies of a new electrophoretic zone protein in labor and the puerperium and in newborn infants. Am J Obstet Gynec 84:199–205
Anderson JM, Stimson WH, Kelly F (1976) Preclinical warning of recrudescent mammary cancers by pregnancy-associated alpha-macroglobin. Br J Surg 63:819–827
Anderson JM, Stimson WH, Gettinby G, Jhunjhunwala J, Burt RW (1979) Detection of mammary micrometastases by pregnancy-associated α2-glycoprotein and carcinoembryonic antigen. Eur J Cancer 15:709–714
Bagshawe KD, Bohn H, Lequin RM, Sizaret Ph (1980) Concentrations of pregnancy specific β-1-glycoprotein, chorionic gonadotrophin and α2-PAG in serum of patients with trophoblastic tumours during chemotherapy. (in press)
Bauer HW, Husfeldt J (1976) Schwangerschaftsass. α2 Glykoprotein ein biochemischer Parameter im Therapieverlauf des Mammakarzinoms. Z Immun Forsch 152:74
Bauer WW, Hasselblatt J, Husfeldt KJ, Bohn H (1977a) Serologische Mammakarzinomverlaufskontrolle mit Hilfe des schwangerschaftsasoziierten α2-Glykoproteins. Langenbecks Arch Chir [Suppl Chir Forum] 69–72
Bauer HW, Deutschmann KEW, Peter HH, Bohn H (1977b) Pregnancy-associated α2-glycoprotein in malignant melanoma. Eur J Cancer 15:123–126
Bauer HW, Bohn H (1978a) Schwangerschaftsspezifische und schwangerschaftsassoziierte Proteine in der Diagnostik und Verlaufskontrolle maligner Erkrankungen. Klin Wochenschr 56:531–534
Bauer HW, Bohn H, Ax W (1978b) Immunologische Potenz des schwangerschaftsassoziierten α2-Glykoproteins. Onkologie 1:119–121
Bauer HW, Gropp C, Bohn H (1978c) Schwangerschaftsassoziiertes α2-Glykoprotein im Serum von Patienten mit Bronchialkarzinomen. Prax Pneumol 32:194–198
Bauer HW, Kraus H (1978d) α2-PAG-Serumkonzentrationen bei gynäkologischen Karzinomen. Onkologie 1:180–183
Bauer HW, Husfeldt J, Bohn H (1979) On the occurence of the pregnancy-associated α2-glycoprotein (α2-PAG) in breast cancer patients. Verh Dtsch Krebs-Ges 2:152
Beckmann G (1976) The pregnancy zone protein and abortion. Acta Obstet Gynec Scand 53:177–180
Berg K (1966) An inherited X-linked serum system in men. J Exp Med 123:379–384
Berne BH, Bohn H, Hofmann R, Klausch B, Straube W, Horne CHW, Kaskuwa R, Rittner Ch, Stomson W, Than GN (1975) Standartisation of nomenclature for pregnancy-associated α2-glycoprotein. Lancet 1:367
Berne BH (1973) α2-pregnoglobulin — a pregnancy-associated macroglobulin elevated by estrogen and oral contraceptive administration. JRCS Med Sci 1:73–74
Bohn H (1971) Nachweis und Charakterisierung von Schwangerschaftsproteinen in der menschlichen Plazenta, sowie ihre quantitative immunologische Bestimmung im Serum schwangerer Frauen. Arch Gynäk 210:440–447
Bohn H (1972) Charakterisierung der schwangerschaftsassoziierten Glyko-Proteine als Akute Phasenproteine. Arch Gynäk 213:54–59 (1972)
Bohn H (1973) Detection, characterisation and diagnostic significance of human pregnancy-associated glycoproteins. Blut 26:205–209
Bohn H, Kranz T (1973b) Untersuchungen über die Bindung von Steroidhormonen an menschliche Schwangerschaftsproteine. Arch Gynäk 215:63–69
Bohn H (1974) Immunchemical determination of human pregnancy proteins. Arch Gynäk 217:219–224
Bohn H, Winkler W (1976) Isolierung und Charakterisierung des schwangerschaftsassoziierten α-2-Glykoproteins (α-2-PAG). Blut 33:377–381
Bundschuh G (1966) Xh — ein genetisch determiniertes α-2-Globulin. Acta Biol Med Germ 17:349–354
Burt MG, Ratcliff JG, Stack BHR, Cuthberg J, Kennedy RS, Corker CS, Franchimont P, Spilg WGS, Stimson H (1978) Serum biochemical marker in lung cancer. Br J Cancer 37:714–717
Damber MG, Von Schoultz B, Stigbrand T (1976b) On the occurence of the pregnancy zone protein (PZ) in Gynaecological cancer. Arch Gynäk 221:97–101
Damber MG, Schoultz B von, Stigbrand T, Tärnvik A (1975) Inhibition of the mixed lymphocyte reaction by the pregnancy zone protein. FEBS Lett 58:29–32
Damber MG, Schoultz B von, Stigbrand T, Carlström KH (1976) A radioimmunoassay for the pregnancy zone protein. Clin Chem Acta 66:85–88
Horne CHW, McLay ALCY, Thomas MA, Travadia HB, Carmichael J, Mallison AC, Laiwah AACY, McSween RNM (1973) Studies of pregnancy-associated globulin. Clin Exp Immunol 13:603–609
Horne CHW, Bohn H, McLay ALC, Wood FH, Thompson WD (1975) Serum pregnancy-associated α2-glycoprotein (α2-PAG) an “acute phase” protein? Behring Inst Mitt 58:50–53
Horne CHW, Bohn H, Towler CM (1976) Pregnancy-associated α2-glycoprotein. In: Klopper A (ed) Symposium on plasma hormone assays in assessment of fetoplacental function. Livingstone, Edingburgh, pp 136–140
Lundgren E, Damber MG, Roos G, Schoultz B von, Stigbrand I, Nilsson K (1979) Cell lines with spontaneous secretion of pregnancy-associated α2-globulin. Int J Cancer 24:45–48
McLaren JA, Reid DF, Konugres AA, Allen IH Jr (1966) Pal, a new inherited α2 globulin of human serum. Vox Sanquis 2:553–560
McLaren JA, Thornes RD, Roby CC, Reid DE (1973a) An immunologic characteristic of the serum of normal pregnancy. Am J Obstet Gynec 78:51–57
Schoultz B von, Stigbrand T (1973a) Purification of the pregnancy zone protein. Acta Obstet Gynec Scand 52:51–57
Schoultz B von, Stigbrand T (1974) Characterisation of the pregnancy zone protein in relation to the other α2-globins of pregnancy. Biochem Biophys Acta 359:303–307
Smithies O (1959) Zone electrophoresis in starch gels and its application to studies of serum proteins. Adv Protein Chemistry 14:65–69
Stimson W, Eubank-Scott L (1972) The isolation and partial characterisation of a new α-macroglobulin from human pregnancy serum. FEBS Lett 23:289–302
Stimson WH, Sinclair JM (1974) An immunoassay for a pregnancy-associated alpha-macroglobulinusing antibody enzyme conjugates. FEBS Lett 47:190
Stimson WH (1975a) Correlation of the blood level of pregnancy-associated alpha-macroglobulin with the clinical course of cancer patients. Lancet 1:777–779
Stimson WH, Blackstock JC (1975b) Synthesis of a pregnancy-associated alpha-macroglobulin by human leucocytes. Experentia 32:371–374
Stimson WH, Anderson JM, Farquhason DM (1977) Pregnancy-associated α2-glycoprotein. Lancet 1:542
Straube W, Klausch B, Hofmann R, Brock K (1972) Immunchemische Untersuchungen zum Problem der Pregnancy-Zone. Arch Gynäk 212:230–234
Teisner B, Mogensen B, Folkersen J, Svehag SE (1977) Trophoblastic tumours, oral contraceptive therapy and pregnancy-associated α2-glycoprotein. Br J Obstet Gynec 84:630–632
Than GN, Csaba JF, Szabo DG (1974) An antigen associated with pregnancy. Lancet 2:1578
Than G, Csaba IF, Szabo DG, Paal M, Ambrus M, Baytai C (1975a) In vitro suppression effect of pregnency-associated α2-glycoprotein on the lymphocyte blastogenetic response. JRCS Med Sci 3:309–312
Than GN, Csaba JE, Karg NJ, Szabo DG, Novak PF (1975b) Pregnancy-associated α2-globulin antigen in pathological pregnancies. JRCS Med 3:94–95
Wood CB, Horne CHW, Towler CM, Bohn H, Baumgart LH (1979) The value of pregnancy-associated α2-glycoprotein (α2-PAG) in patients with colorectal cancer. Clin Oncol 3:396–401
Author information
Authors and Affiliations
Additional information
Dedicated to Prof. Dr. E. Schmiedt to his 60th birthday (20th of November 1980)
Rights and permissions
About this article
Cite this article
Bauer, H.W. The pregnancy-associated α2-glycoprotein (α2-PAG) A tumour marker?. Klin Wochenschr 59, 149–155 (1981). https://doi.org/10.1007/BF01477474
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01477474
Key words
- Pregnancy-associated α2-glycoprotein
- Pregnancy
- Malignant tumours
- Seroscreening
- Monitoring of tumour therapy